{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:10:42Z","timestamp":1779433842207,"version":"3.53.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00417-026-07146-y","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:06:15Z","timestamp":1770894375000},"page":"1649-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A literature review of macular holes in age-related macular degeneration: insights into the pathogenesis, prognosis and surgical outcomes"],"prefix":"10.1007","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-4854","authenticated-orcid":false,"given":"Evita Evangelia","family":"Christou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsveta","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kiraly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando J","family":"Huelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"MacLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assad","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"7146_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/IAE.0000000000000036","volume":"34","author":"R Velez-Montoya","year":"2014","unstructured":"Velez-Montoya R, Oliver SC, Olson JL et al (2014) Current knowledge and trends in age-related macular degeneration: genetics, epidemiology, and prevention. Retina 34:423\u2013441","journal-title":"Retina"},{"key":"7146_CR2","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392:1147\u20131159","journal-title":"Lancet"},{"key":"7146_CR3","first-page":"Cd005139","volume":"8","author":"SD Solomon","year":"2014","unstructured":"Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS (2014) Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database SystRev 8:Cd005139","journal-title":"Cochrane Database SystRev"},{"issue":"10411","key":"7146_CR4","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","volume":"402","author":"JS Heier","year":"2023","unstructured":"Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Mon\u00e9s J, Singh RP, Ribeiro R, Wykoff CC (2023) OAKS and DERBY study investigators. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials. Lancet 402(10411):1434\u20131448","journal-title":"Lancet"},{"key":"7146_CR5","doi-asserted-by":"crossref","unstructured":"Carl\u00e0 MM, Mottola F, Cusato M, Oreste G, Campaniello G, Mateo C, Couturier A, Philippakis E, Caporossi T, Rizzo S Vitreoretinal interface abnormalities in age-related macular degeneration: Prevalence, pathophysiology, and reciprocal influence. Surv Ophthalmol 2025 Jul 23:S0039-6257(25)00126-2.","DOI":"10.1016\/j.survophthal.2025.07.010"},{"issue":"6","key":"7146_CR6","first-page":"1203","volume":"122","author":"TA Ciulla","year":"2015","unstructured":"Ciulla TA, Ying GS, Maguire MG et al (2015) Influence of the vitreomacular interface on treatment outcomes in the comparison of age-related macular degeneration treatments trials. Ophthalmol Jun 122(6):1203\u20131211","journal-title":"Ophthalmol Jun"},{"issue":"5","key":"7146_CR7","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1755-3768.2008.01210.x","volume":"86","author":"S Schulze","year":"2008","unstructured":"Schulze S, Hoerle S, Mennel S, Kroll P (2008) Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol (Copenh) Aug 86(5):470\u2013481","journal-title":"Acta Ophthalmol (Copenh) Aug"},{"issue":"6","key":"7146_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.survophthal.2012.01.011","volume":"57","author":"ARH Simpson","year":"2012","unstructured":"Simpson ARH, Petrarca R, Jackson TL (2012) Vitreomacular adhesion and neovascular age-related macular degeneration. Surv Ophthalmol Nov 57(6):498\u2013509","journal-title":"Surv Ophthalmol Nov"},{"issue":"7","key":"7146_CR9","first-page":"1236","volume":"39","author":"D Kumawat","year":"2019","unstructured":"Kumawat D, Venkatesh P, Brar AS, Sahay P, Kumar V, Chandra P, Chawla R (2019) Atyp MACULAR HOLES Retina 39(7):1236\u20131264","journal-title":"Atyp MACULAR HOLES Retina"},{"key":"7146_CR10","doi-asserted-by":"crossref","unstructured":"Kumar V, Shankar J (2012 Winter) Lamellar macular hole after Ranibizumab in a patient with neovascular age-related macular degeneration and vitreomacular adhesion. Retin Cases Brief Rep 6(1):109\u2013110","DOI":"10.1097\/ICB.0b013e31820a2f30"},{"key":"7146_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1089\/jop.2009.0140","volume":"26","author":"CR Clemens","year":"2010","unstructured":"Clemens CR, Holz FG, Meyer CH (2010) Macular hole formation in the presence of a pigment epithelial detachment after three consecutive intravitreal antivascular endothelial growth factor injections. J Ocul Pharmacol Ther 26:297\u2013299","journal-title":"J Ocul Pharmacol Ther"},{"key":"7146_CR12","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","volume":"120","author":"JS Duker","year":"2013","unstructured":"Duker JS, Kaiser PK, Binder S et al (2013) The international vitreomacular traction study group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611\u20132619","journal-title":"Ophthalmology"},{"issue":"4","key":"7146_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","volume":"96","author":"RJ Van Geest","year":"2012","unstructured":"Van Geest RJ, Lesnik-Oberstein SY, Tan HS, Mura M, Goldschmeding R, Van Noorden CJ, Klaassen I, Schlingemann RO (2012) A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 96(4):587\u2013590","journal-title":"Br J Ophthalmol"},{"key":"7146_CR14","doi-asserted-by":"crossref","unstructured":"Rao P, Yonekawa Y, Abbey AM, Shah AA, Wolfe JD, Faia LJ (2017) Prevalence and Surgical Outcomes of Macular Hole in Eyes with Age-Related Macular Degeneration. Ophthalmol Retina Mar-Apr 1(2):158\u2013164","DOI":"10.1016\/j.oret.2016.09.014"},{"issue":"12","key":"7146_CR15","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/S0161-6420(00)00417-6","volume":"107","author":"DM Berinstein","year":"2000","unstructured":"Berinstein DM, Hassan TS, Williams GA, Margherio RR, Ruby AJ, Garretson BR (2000) Surgical repair of full-thickness idiopathic macular holes associated with significant macular Drusen. Ophthalmology 107(12):2233\u20132239","journal-title":"Ophthalmology"},{"issue":"7","key":"7146_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.ophtha.2009.01.052","volume":"116","author":"CA McCannel","year":"2009","unstructured":"McCannel CA, Ensminger JL, Diehl NN, Hodge DN (2009) Population-based incidence of macular holes. Ophthalmology 116(7):1366\u20131369","journal-title":"Ophthalmology"},{"key":"7146_CR17","first-page":"933","volume":"99","author":"R Klein","year":"1992","unstructured":"Klein R, Klein BEK, Linton KL (1992) Prevalence of age-related maculopathy. Beaver Dam Eye Study Ophthalmol 99:933\u2013943","journal-title":"Beaver Dam Eye Study Ophthalmol"},{"key":"7146_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0161-6420(90)32465-X","volume":"97","author":"DR Guyer","year":"1990","unstructured":"Guyer DR, Green WR, de Bustros S, Fine SL (1990) Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 97:1045\u20131051","journal-title":"Ophthalmology"},{"issue":"10","key":"7146_CR19","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1097\/IAE.0000000000003141","volume":"41","author":"G Rabina","year":"2021","unstructured":"Rabina G, Pillar S, Nemet A, Mimouni M, Levinger N, Chowers I, Ehrlich R, Gal-Or O, Barequet D, Rosenblatt A, Moisseiev E, Greifner H, Magal I, Segal O (2021) Full-thickness macular hole in age-related macular degeneration patients with two distinct entities: A multicenter study. Retina 41(10):2066\u20132072","journal-title":"Retina"},{"issue":"10","key":"7146_CR20","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/IAE.0000000000003148","volume":"41","author":"KL Kim","year":"2021","unstructured":"Kim KL, Han JM, Kim MS, Park SJ, Kim SW, Kim JH, Kim M, Lee CS, Kang HG, Lee JY, Woo SJ (2021) Macular hole associated with age-related macular degeneration: pathogenesis and surgical outcomes. Retina 41(10):2079\u20132087","journal-title":"Retina"},{"issue":"3","key":"7146_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/ICB.0000000000000786","volume":"15","author":"OA Shif","year":"2021","unstructured":"Shif OA, Katz MSJ (2021) Surgical management of full-thickness macular hole superimposed on exudative age-related macular degeneration. Retina Cases Brief Rep 15(3):211\u2013213","journal-title":"Retina Cases Brief Rep"},{"issue":"2","key":"7146_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/2474126418825220","volume":"3","author":"OM Ismail","year":"2019","unstructured":"Ismail OM, Mason L, Mason JO (2019) Efficacy of vitrectomy and macular hole repair in eyes with dry Age-Related macular degeneration. J VitreoRetinal Dis 3(2):94\u201398","journal-title":"J VitreoRetinal Dis"},{"issue":"3","key":"7146_CR23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1177\/1120672120921376","volume":"31","author":"Z Michalewska","year":"2021","unstructured":"Michalewska Z, Nawrocki J (2021) Vitrectomy with the inverted internal limiting membrane flap technique in eyes with full-thickness macular hole and dry age-related macular degeneration. Eur J Ophthalmol 31(3):1320\u20131325","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"7146_CR24","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/IAE.0000000000002532","volume":"40","author":"A Francone","year":"2020","unstructured":"Francone A, Yun L, Kothari N, Cheng I, Farajzadeh M, Govetto A, Hubschman JP (2020) Lamellar macular holes in the presence of age-related macular degeneration. Retina 40(6):1079\u20131086","journal-title":"Retina"},{"issue":"4S","key":"7146_CR25","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.ophtha.2020.01.033","volume":"127","author":"R Klein","year":"2020","unstructured":"Klein R, Klein BEK, Linton KLP (2020) Prevalence of Age-related maculopathy: the beaver dam eye study. Ophthalmology 127(4S):S122\u2013S132","journal-title":"Ophthalmology"},{"issue":"4S","key":"7146_CR26","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.ophtha.2019.12.028","volume":"127","author":"EY Chew","year":"2020","unstructured":"Chew EY (2020) The landmark beaver dam eye study ushered in modern epidemiologic research in Age-Related macular degeneration. Ophthalmology 127(4S):S120\u2013S121","journal-title":"Ophthalmology"},{"key":"7146_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S0002-9394(14)70212-0","volume":"119","author":"AC Bird","year":"1995","unstructured":"Bird AC (1995) Retinal photoreceptor dystrophies LI. Edward Jackson memorial lecture. Am J Ophthalmol 119:543\u2013562","journal-title":"Am J Ophthalmol"},{"key":"7146_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2016.02.008","volume":"164","author":"A Govetto","year":"2016","unstructured":"Govetto A, Dacquay Y, Farajzadeh M et al (2016) Lamellar macular hole: two distinct clinical entities? Am J Ophthalmol 164:99\u2013109","journal-title":"Am J Ophthalmol"},{"key":"7146_CR29","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto I, Lutty G (2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Aspects Med 33:295\u2013317","journal-title":"Mol Aspects Med"},{"key":"7146_CR30","first-page":"31","volume":"5","author":"R Adler","year":"1999","unstructured":"Adler R, Curcio C, Hicks D et al (1999) Cell death in age-related macular degeneration. Mol Vis 5:31","journal-title":"Mol Vis"},{"key":"7146_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0014-4835(02)00332-9","volume":"76","author":"N Gupta","year":"2003","unstructured":"Gupta N, Brown KE, Milam AH (2003) Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 76:463\u2013471","journal-title":"Exp Eye Res"},{"key":"7146_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/glia.440140402","volume":"14","author":"JM Provis","year":"1995","unstructured":"Provis JM, Penfold PL, Edwards AJ, van Driel D (1995) Human retinal microglia: expression of immune markers and relationship to the glia limitans. Glia 14:243\u2013256","journal-title":"Glia"},{"issue":"12","key":"7146_CR33","first-page":"750","volume":"17","author":"O Segal","year":"2015","unstructured":"Segal O, Ferencz JR, Mimouni M, Nesher R, Cohen P, Nemet AY (2015) Lamellar macular holes associated with End-Stage exudative Age-Related macular degeneration. Isr Med Assoc J 17(12):750\u2013754","journal-title":"Isr Med Assoc J"},{"key":"7146_CR34","doi-asserted-by":"crossref","unstructured":"Theodossiadis P, Charonis A, Panagiotidis D, Papathanassiou M, Petrou P (2010 Nov-Dec) Vitrectomy for treatment of a lamellar hole in a patient with exudative macular degeneration: the role of vitreous traction elimination. Eur J Ophthalmol 20(6):1086\u20131088","DOI":"10.1177\/112067211002000613"},{"key":"7146_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12886-015-0029-8","volume":"15","author":"JH Lee","year":"2015","unstructured":"Lee JH, Lee T, Lee SC, Lee CS (2015) Disappearance of soft Drusen and subsequent development of choroidal neovascularization following macular hole surgery: a case report. BMC Ophthalmol 15:43. https:\/\/doi.org\/10.1186\/s12886-015-0029-8PMID: 25928705; PMCID: PMC4424516","journal-title":"BMC Ophthalmol"},{"key":"7146_CR36","doi-asserted-by":"crossref","unstructured":"Chan EW, Sun V, Chen JC (2020 Summer) Reopening of macular hole after intravitreal Aflibercept for neovascular age-related macular degeneration. Retin Cases Brief Rep 14(3):255\u2013259","DOI":"10.1097\/ICB.0000000000000688"},{"key":"7146_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/cxo.12009","volume":"97","author":"HA Tufan","year":"2014","unstructured":"Tufan HA, Gencer B, Kara S (2014) Macular hole after intravitreal bevacizumab injection for choroidal neovascularisation. Clin Exp Optom 97:178\u2013180","journal-title":"Clin Exp Optom"},{"key":"7146_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.2147\/CIA.S135364","volume":"12","author":"SA Kabanarou","year":"2017","unstructured":"Kabanarou SA, Xirou T, Mangouritsas G, Garnavou-Xirou C, Boutouri E, Gkizis I, Chatziralli I (2017) Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration. Clin Interv Aging 12:911\u2013915","journal-title":"Clin Interv Aging"},{"key":"7146_CR39","doi-asserted-by":"crossref","unstructured":"Ringeisen AL, Parke DW 3rd, Dev S (2019 Winter) Characteristics and outcomes of Full-thickness macular hole repair in patients receiving Anti-VEGF injections for neovascular Age-related macular degeneration. Int Ophthalmol Clin 59(1):127\u2013135","DOI":"10.1097\/IIO.0000000000000248"},{"issue":"9","key":"7146_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.oftal.2020.08.011","volume":"96","author":"Z Kayaarasi Ozturker","year":"2021","unstructured":"Kayaarasi Ozturker Z, Akca Bayar S, Yaman Pinarci E, Kurt RA, Akkoyun I, Yilmaz G (2021) Atypical macular hole formation after Anti-VEGF therapy for neovascular age-related macular degeneration: coincidence or consequence? Arch Soc Esp Oftalmol (Engl Ed) 96(9):455\u2013461","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"1","key":"7146_CR41","doi-asserted-by":"publisher","first-page":"NP16","DOI":"10.1177\/11206721241286708","volume":"35","author":"SH Lee","year":"2025","unstructured":"Lee SH, Lee MY (2025) Full thickness macular hole after intravitreal Brolucizumab injection in neovascular age-related macular degeneration. Eur J Ophthalmol 35(1):NP16\u2013NP19","journal-title":"Eur J Ophthalmol"},{"key":"7146_CR42","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1097\/IAE.0b013e31828991d6","volume":"33","author":"TL Jackson","year":"2013","unstructured":"Jackson TL, Nicod E, Angelis A, Grimaccia F, Prevost AT, Simpson ARH et al (2013) Vitreous attachment in age-relatemacular degeneration, diabetic macular edema, and retinavein occlusion: a systematic review and metaanalysis. Retina 33:1099\u20131108","journal-title":"Retina"},{"key":"7146_CR43","doi-asserted-by":"crossref","unstructured":"Rajeswaren V, Trivedi V, Yoganathan P Macular hole after anti-Vascular endothelial growth factor injection: A review. Surv Ophthalmol 2025 Aug 14:S0039-6257(25)00140-7.","DOI":"10.1016\/j.survophthal.2025.08.009"},{"issue":"8","key":"7146_CR44","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1007\/s00417-025-06848-z","volume":"263","author":"M Pellegrini","year":"2025","unstructured":"Pellegrini M, Adamo GG, Vivarelli C, Sarti L, Talli PM, Nasini F, Parmeggiani F, Mura M (2025) Vitrectomy with macular peeling in eyes with vitreomacular interface disorders and nonexudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 263(8):2203\u20132208","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7146_CR45","doi-asserted-by":"crossref","unstructured":"Torabi H, Jadidi K, Naderi M (2018 Sep-Dec) Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration. Oman J Ophthalmol 11(3):277\u2013279","DOI":"10.4103\/ojo.OJO_33_2017"},{"key":"7146_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000319827","volume":"1","author":"E Moisseiev","year":"2010","unstructured":"Moisseiev E, Goldstein M, Loewenstein A et al (2010) Macular hole following intravitreal bevacizumab injection in choroidal neovascularization caused by age-related macular degeneration. Case Rep Ophthalmol 1:36\u201341","journal-title":"Case Rep Ophthalmol"},{"key":"7146_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2415-14-114","volume":"14","author":"T Okamoto","year":"2014","unstructured":"Okamoto T, Shinoda H, Kurihara T, Nagai N, Tsubota K, Ozawa Y (2014) Intraoperative and fluorescein angiographic findings of a secondary macular hole associated with age-related macular degeneration treated by Pars plana vitrectomy. BMC Ophthalmol 14:114","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"7146_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1755-3768.2008.01226.x","volume":"87","author":"G Querques","year":"2009","unstructured":"Querques G, Souied EH, Soubrane G (2009) Macular hole following intravitreal Ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration. Acta Ophthalmol 87(2):235\u2013237","journal-title":"Acta Ophthalmol"},{"key":"7146_CR49","first-page":"e12872","volume":"13","author":"A Karamitsos","year":"2021","unstructured":"Karamitsos A, Sorkou KN, Bhagey J et al (2021) An uncommon Aflibercept side effect: full thickness macular hole formation after intravitreal injections in patients with pre-existing vitreomacular traction. Cureus 13:e12872","journal-title":"Cureus"},{"key":"7146_CR50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3341\/jkos.2010.51.5.774","volume":"51","author":"YJ Jo","year":"2010","unstructured":"Jo YJ, Kim KN, Lee JE et al (2010) Macular hole following intravitreal Ranibizumab injections for choroidal neovascularization. J Korean Ophthalmol Soc 51:774\u2013778","journal-title":"J Korean Ophthalmol Soc"},{"key":"7146_CR51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ajo.2005.01.028","volume":"140","author":"GG Emerson","year":"2005","unstructured":"Emerson GG, Ghazi NG (2005) Spontaneous Rip of the retinal pigment epithelium with a macular hole in neovascular age-related macular degeneration. Am J Ophthalmol 140:316\u2013318","journal-title":"Am J Ophthalmol"},{"key":"7146_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/112067211002000235","volume":"20","author":"V Grigoropoulos","year":"2010","unstructured":"Grigoropoulos V, Emfietzoglou J, Nikolaidis P et al (2010) Full-thickness macular hole after intravitreal injection of Ranibizumab in a patient with retinal pigment epithelium detachment and tear. Eur J Ophthalmol 20:469\u2013472","journal-title":"Eur J Ophthalmol"},{"key":"7146_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12886-015-0021-3","volume":"15","author":"Y Oshima","year":"2015","unstructured":"Oshima Y, Apte RS, Nakao S et al (2015) Full thickness macular hole case after intravitreal Aflibercept treatment. BMC Ophthalmol 15:30","journal-title":"BMC Ophthalmol"},{"key":"7146_CR54","first-page":"1287","volume":"6","author":"HN Oh","year":"2012","unstructured":"Oh HN, Lee JE, Kim HW et al (2012) Occult choroidal neovascularization after successful macular hole surgery treated with Ranibizumab. Clin Ophthalmol 6:1287\u20131291","journal-title":"Clin Ophthalmol"},{"key":"7146_CR55","first-page":"208","volume":"44","author":"C Panthier","year":"2013","unstructured":"Panthier C, Querques G, Zerbib J et al (2013) Spontaneous combined full-thickness retinal and pigment epithelium macular hole in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 44:208\u2013210","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"7146_CR56","doi-asserted-by":"publisher","first-page":"101154","DOI":"10.1016\/j.ajoc.2021.101154","volume":"23","author":"PS Meyer","year":"2021","unstructured":"Meyer PS, Kammann MT, Meyer CH (2021) Vitrectomy in full thickness macular holes on top of a pigment epithelial detachment in age-related macular degeneration (AMD). Surgical consideration and review of the literature. Am J Ophthalmol Case Rep 23:101154","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"4","key":"7146_CR57","doi-asserted-by":"publisher","first-page":"AMD78","DOI":"10.1167\/iovs.18-24426","volume":"59","author":"MS Singh","year":"2018","unstructured":"Singh MS, MacLaren RE (2018) Stem cell treatment for Age-Related macular degeneration: the challenges. Invest Ophthalmol Vis Sci 59(4):AMD78\u2013AMD82","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"7146_CR58","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/14712598.2017.1346079","volume":"17","author":"P Bracha","year":"2017","unstructured":"Bracha P, Moore NA, Ciulla TA (2017) Induced pluripotent stem cell-based therapy for age-related macular degeneration. Expert Opin Biol Ther 17(9):1113\u20131126","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"7146_CR59","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.preteyeres.2007.07.001","volume":"26","author":"L da Cruz","year":"2007","unstructured":"da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P (2007) RPE transplantation and its role in retinal disease. Prog Retin Eye Res 26(6):598\u2013635","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"7146_CR60","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","volume":"36","author":"L da Cruz","year":"2018","unstructured":"da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ (2018) Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol 36(4):328\u2013337","journal-title":"Nat Biotechnol"},{"issue":"10","key":"7146_CR61","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/diagnostics14101005","volume":"14","author":"L da Cruz","year":"2024","unstructured":"da Cruz L, Soomro T, Georgiadis O, Nommiste B, Sagoo MS, Coffey P, London Project Study Group (2024) The fate of RPE cells following hESC-RPE patch transplantation in haemorrhagic wet AMD: Pigmentation, extension of Pigmentation, thickness of Transplant, assessment for proliferation and visual Function-A 5 Year-Follow up. Diagnostics (Basel) 14(10):1005","journal-title":"Diagnostics (Basel)"},{"key":"7146_CR62","doi-asserted-by":"publisher","first-page":"3162478","DOI":"10.1155\/2019\/3162478","volume":"2019","author":"R Nuzzi","year":"2019","unstructured":"Nuzzi R, Tridico F (2019) Perspectives of autologous mesenchymal Stem-Cell transplantation in macular hole surgery: A review of current findings. J Ophthalmol 2019:3162478","journal-title":"J Ophthalmol"},{"issue":"11","key":"7146_CR63","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00417-018-4097-3","volume":"256","author":"X Zhang","year":"2018","unstructured":"Zhang X, Liu J, Yu B, Ma F, Ren X, Li X (2018) Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes. Graefes Arch Clin Exp Ophthalmol 256(11):2041\u20132052","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"7146_CR64","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/S0161-6420(97)30118-3","volume":"104","author":"A Banker","year":"1997","unstructured":"Banker A, Freeman W, Kim J, Vitrectomy for Macular Hole Study Group (1997) Vision-threatening complications of surgery for full-thickness macular holes. Ophthalmology 104(9):1442\u20131452 discussion 1452\u20131453","journal-title":"Ophthalmology"},{"issue":"2","key":"7146_CR65","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/00006982-200104000-00018","volume":"21","author":"FG Holz","year":"2001","unstructured":"Holz FG, Staudt S (2001) Disappearance of soft Drusen following macular hole surgery. Retina 21(2):184\u2013186","journal-title":"Retina"},{"key":"7146_CR66","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/eye.2013.35","volume":"27","author":"S Dithmar","year":"2013","unstructured":"Dithmar S, Pollithy S, Ach T (2013) Disappearance of central confluent soft Drusen following vitrectomy and ILM peeling. Eye 27:779\u2013781","journal-title":"Eye"},{"key":"7146_CR67","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1001\/archopht.118.1.131","volume":"118","author":"NA Chaudhry","year":"2000","unstructured":"Chaudhry NA, Flynn HWJ, Smiddy WE, Thompson JT (2000) Macular hole surgery in the presence of prominent macular Drusen. Arch Ophthalmol 118:131\u2013132","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"7146_CR68","doi-asserted-by":"publisher","first-page":"366","DOI":"10.5507\/bp.2022.047","volume":"167","author":"A Tarkova","year":"2023","unstructured":"Tarkova A, Hejsek L, Jurecka T, Wolkova P, Rubesova M, Hackl M (2023) Pars plana vitrectomy for vitreoretinal interface disorders coincident with intermediate stage age-related macular degeneration. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 167(4):366\u2013369","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"12","key":"7146_CR69","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1038\/s41433-022-02012-7","volume":"36","author":"P Ramtohul","year":"2022","unstructured":"Ramtohul P, Cabral D, Klancnik JM, Curcio CA, Freund KB (2022) Soft Drusen accumulation within a full-thickness macular hole: new insights into the mechanisms of lipid cycling pathways in age-related macular degeneration. Eye (Lond) 36(12):2346\u20132347","journal-title":"Eye (Lond)"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07146-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07146-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:03:14Z","timestamp":1779433394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07146-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7146"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07146-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"1 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"for this version to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any studies with human participants or animals conducted by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"REM is listed as an inventor on a patent for RPGR gene therapy owned and licensed by the University of Oxford; Novartis, Scribe Therapeutics, Biogen Inc., AGTC, and is a director of Beacon Therapeutics, which has not influenced the outcomes of this work. The other authors report no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}